{
  "thread": {
    "uuid": "e207b094376ae0389e0f0039993a90bb511575bd",
    "url": "https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "site_full": "www.marketbeat.com",
    "site": "marketbeat.com",
    "site_section": "https://news.google.com/search?q=here%20when%3A1h&hl=en-US&gl=US&ceid=US%3Aen",
    "site_categories": [
      "investing",
      "financial_news",
      "finance",
      "stocks",
      "economy, business and finance"
    ],
    "section_title": "Google News - Search",
    "site_title": "MarketBeat: Stock Market News and Research Tools",
    "title": "Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 5.2% - Here's Why",
    "title_full": "Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 5.2% - Here's Why",
    "published": "2026-01-15T07:43:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://www.marketbeat.com/logos/ampliphi-biosciences-corp-logo-1200x675.jpg?v=20241113074823",
    "performance_score": 0,
    "domain_rank": 17792,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "e207b094376ae0389e0f0039993a90bb511575bd",
  "url": "https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
  "ord_in_thread": 0,
  "author": "MarketBeat",
  "published": "2026-01-15T07:43:00.000+02:00",
  "title": "Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 5.2% - Here's Why",
  "text": "Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 5.2% - Here's Why Written by MarketBeat January 14, 2026 Share Link copied to clipboard. Image from MarketBeat Media, LLC. Key Points Shares fell 5.2% , trading as low as $5.89 and last at $6.68, on volume of 78,647 shares — about a 91% drop from the average session volume of 842,200 shares. The stock's technicals show a 50‑day simple moving average of $6.38 and a 200‑day simple moving average of $4.13, leaving the current price above both averages. Ampliphi is a clinical‑stage biopharma focused on combating antibiotic resistance; its lead candidate, XF‑73 , is a topical nasal decolonization treatment for Staphylococcus aureus in high‑risk surgical patients. MarketBeat previews the top five stocks to own by February 1st . Shares of Ampliphi Biosciences Corp ( NYSEAMERICAN:APHB - Get Free Report ) fell 5.2% during mid-day trading on Wednesday . The stock traded as low as $5.89 and last traded at $6.68. 78,647 shares changed hands during trading, a decline of 91% from the average session volume of 842,200 shares. The stock had previously closed at $7.05. Get Ampliphi Biosciences alerts: Sign Up Ampliphi Biosciences Stock Down 5.2%\nThe stock has a 50-day simple moving average of $6.38 and a 200 day simple moving average of $4.13. Ampliphi Biosciences Company Profile ( Get Free Report )\nAmpliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company's core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.\nThe company's lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures. Recommended Stories\nThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.\nShould You Invest $1,000 in Ampliphi Biosciences Right Now? Before you consider Ampliphi Biosciences, you'll want to hear this.\nMarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.\nWhile Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.\nView The Five Stocks Here\nBeginner's Guide To Retirement Stocks Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.\nGet This Free Report Like this article? Share it with a colleague. Link copied to clipboard.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->business and market analysis"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://www.facebook.com/sharer/sharer.php?u=https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://www.americanconsumernews.net/scripts/standalone/viewcount.ashx?type=h&id=3141577&domain=marketbeat.com&referrer=",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20%24APHB%20%23APHB%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://americanconsumernews.net/scripts/standalone/viewcount.ashx?type=h&id=3141577&domain=marketbeat.com&referrer=",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14",
    "https://www.facebook.com/sharer/sharer.php",
    "https://api.stocktwits.com/widgets/share?via=MarketBeat&body=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20%24APHB%20%23APHB%20https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14",
    "https://www.facebook.com/sharer/sharer.php?u=https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14",
    "https://www.linkedin.com/cws/share?mini=true&url=https://www.marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14",
    "https://linkedin.com/cws/share?mini=true&url=https://marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://www.linkedin.com/cws/share",
    "https://www.americanconsumernews.net/scripts/standalone/viewcount.ashx",
    "https://api.stocktwits.com/widgets/share",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20https://marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://twitter.com/intent/tweet?text=Ampliphi+Biosciences+(NYSEAMERICAN%3aAPHB)+Trading+Down+5.2%25++-+Here%27s+Why%20%24APHB%20%23APHB%20https://marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/",
    "https://twitter.com/intent/tweet",
    "https://facebook.com/sharer/sharer.php?u=https://marketbeat.com/instant-alerts/ampliphi-biosciences-nyseamericanaphb-trading-down-52-heres-why-2026-01-14/"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": [
      {
        "name": "Ampliphi Biosciences",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "MarketBeat Media, LLC",
        "sentiment": "none",
        "tickers": [
          {
            "ticker": null,
            "exchange": null
          }
        ]
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T07:47:46.701+02:00",
  "updated": "2026-01-15T07:49:16.000+02:00"
}